Statins and atrial fibrillation - mini - review on recent evidence
| 1 | Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland |
| 2 | Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland |
CORRESPONDING AUTHOR
Maciej Banach
Department of Cardiology, Medical University of Lodz, Poland, Sterlinga 1/3, 91-425 Lodz, Poland
Department of Cardiology, Medical University of Lodz, Poland, Sterlinga 1/3, 91-425 Lodz, Poland
Publication date: 2017-01-17
Heart Beat 2016;1:43–46
KEYWORDS
TOPICS
ABSTRACT
Atrial fibrillation (AF) is the most common clinically significant cardiac arrhythmia, and it is associated with higher morbidity and mortality. However, treatment options for AF are still limited and often not effective. Studies indicated that statins might be associated with a decreased risk of incidence or recurrence of AF. The following review summarizes the key findings of the recent published studies.
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.